Funding for this research was provided by:
Università degli Studi di Roma La Sapienza
Received: 5 February 2021
Revised: 20 April 2021
Accepted: 21 April 2021
First Online: 3 May 2021
: During the conduct of the study SR received fee as speaking honoraria from Merck Serono, Biogen, travel grant from Biogen, Merck Serono, fee as advisory board consultant from Merck Serono and Novartis; MP has nothing to disclose; LDG received speaking onoraria from Genzyme and Novartis, travel grant from Biogen, Merk, Teva, consulting fee from Genzyme, Merk and Novartis; FDL has nothing to disclose; CG received founding for travel and speaker honoraria from Bracco; FG has nothing to disclose;NP received speaker fees from Biogen Idec and mission support from Novartis; ST reports grants from FISM; CP received consulting and lecture fees and research funding and travel grants from Almirall, Bayer, Biogen, Genzyme, Merck Serono, Novartis, Roche and Teva; PP received founding for travel from Novartis, Genzyme and Bracco and speaker honoraria from Biogen.
: The study protocol reported in this manuscript has been approved by the ethical committee of Policlinico Umberto I, Sapienza, University of Rome, Italy, and has been performed in accordance with ethical standards listed in the Declaration of Helsinki. Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals.
: All subjects gave their informed consent prior to study inclusion. Details that might disclose their identity were omitted.